BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:40 PM
 | 
Nov 04, 2008
 |  BC Extra  |  Company News

Amylin, Alkermes fall on possible delay

Shares of Amylin (NASDAQ:AMLN) and Alkermes (NASDAQ:ALKS) fell on Tuesday after the companies disclosed in SEC filings that data for exenatide once weekly have not met FDA requirements to demonstrate comparability between product used in clinical trials and product manufactured on a commercial...

Read the full 208 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >